AXQ Capital’s Integra LifeSciences IART Stock Holding History

AXQ Capital’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-23,344	Closed	-$286K	–	694
2025 Q2	$286K	Buy	+23,344	New	+$339K	0.09%	373

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AXQ Capital's IART Position: Q3 2025 in Review

AXQ Capital sold out of Integra LifeSciences (IART) in Q3 2025, closing a stake of 23,344 shares — an estimated $286K sold.

AXQ Capital first reported a position in IART in Q2 2025 and held it in 1 quarter. The position peaked at $286K in Q2 2025. 207 funds tracked by Wall St. Rank hold IART as of Q3 2025.

AXQ Capital reported no remaining Integra LifeSciences position as of Q3 2025 after selling out during the quarter.
AXQ Capital sold 23,344 Integra LifeSciences shares in Q3 2025, an estimated $286K.
AXQ Capital first reported a position in Integra LifeSciences in Q2 2025 and held it in 1 quarter.
AXQ Capital's Integra LifeSciences position peaked at $286K in Q2 2025.
207 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2025.

Based on AXQ Capital's 13F filing for Q3 2025, filed 10 Nov 2025.